Limit search to items available for checkout
Result Page   1 2 3 Next
Save Marked Records Save All On Page
Subjects (1-50 of 132)
United States. Food and Drug Administration -- Rules and practice.
1
2018
E-REPORT
The administration's FDA reforms and reduced biopharmaceutical drug prices
Council of Economic Advisers (U.S.), author.
[Washington, D.C.] : Executive Office of the President of the United States, Council of Economic Advisers, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
2
2014
BOOK
Animal drug user fee agreements : advancing animal health for the public : hearing before the Commit
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. Government Printing Office, 2014.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.L 11/4:S.HRG.113-448    AVAILABLE
3
2017
E-REPORT
Antibiotics, FDA has encouraged development, but needs to clarify the role of draft guidance and dev
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2017.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
4
2012
E-REPORT
Antibiotics FDA needs to do more to ensure that drug labels contain up-to-date information : report
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
5
2018
E-REPORT
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Refo
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
6
2018
BOOK
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Refo
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.J 89/1:115-27    AVAILABLE
7
2017
BOOK
Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security, author.
Washington : U.S. Government Publishing Office, 2017.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.L 11/4:S.HRG.114-700    AVAILABLE
8
2017
E-REPORT
Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security, author.
Washington : U.S. Government Publishing Office, 2017.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
9
1997
MICROFORM
Blood supply FDA oversight and remaining issues of safety : report to the Ranking Minority Member, C
United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1997]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  GA 1.13:PEMD-97-1    AVAILABLE
10
1997
MICROFORM
Blood supply transfusion-associated risks : report to the Ranking Minority Member, Committee on Comm
United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1997]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  GA 1.13:PEMD-97-2    AVAILABLE
11
2009
E-REPORT
Bottled water FDA safety and consumer protections are often less stringent than comparable EPA prote
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
12
2006
BOOK
Committee staff report to the chairman and ranking member : review of the FDA's approval process for
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2006.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.F 49:S.PRT.109-45    AVAILABLE
13
2020
E-REPORT
COVID-19: federal efforts accelerate vaccine and therapeutic development, but tranparency needed on
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
14
2011
E-REPORT
A delicate balance FDA and the reform of the medical device approval process : hearing before the Sp
United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O., 2011.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
15
2011
MICROFORM
A delicate balance : FDA and the reform of the medical device approval process : hearing before the
United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., U.S. G.P.O., 2011.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  Y 4.AG 4:S.HRG.112-92    AVAILABLE
16
2003
E-REPORT
Department of Health and Human Services, Food and Drug Administration applications for FDA approval
United States. General Accounting Office.
Washington, DC : U.S. General Accounting Office, [2003]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
17
2003
E-REPORT
Department of Health and Human Services, Food and Drug Administration food labeling : trans fatty ac
United States. General Accounting Office.
Washington, DC : U.S. General Accounting Office, [2003]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
18
1999
E-REPORT
Dietary Supplement Health and Education Act : is the FDA trying to change the intent of Congress? :
United States. Congress. House. Committee on Government Reform, author.
Washington : U.S. Government Printing Office, 1999.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
19
2013
E-REPORT
Dietary supplements : FDA may have opportunities to expand its use of reported health problems to ov
United States. Government Accountability Office.
[Washington, D.C.] : United States Government Accountability Office, 2013.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
20
2009
E-REPORT
Dietary supplements FDA should take further actions to improve oversight and consumer understanding
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
21
2008
E-REPORT
Drug safety better data management and more inspections are needed to strengthen FDA's foreign drug
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
22
2009
E-REPORT
Drug safety FDA has begun efforts to enhance postmarket safety, but additional actions are needed :
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
23
2010
E-REPORT
Drug safety FDA has conducted more foreign inspections and begun to improve its information on forei
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
24
2016
E-REPORT
Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effective
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2016.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
25
2006
E-REPORT
Drug safety improvement needed in FDA's postmarket decision-making and oversight process : report to
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Government Accountability Office, [2006]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
26
2016
E-REPORT
Drug shortages, certain factors are strongly associated with this persistent public health challenge
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2016.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  099 Electronic Report    AVAILABLE
27
2018-
E-REPORT
Enforcement of the Food, Drug, and Cosmetic Act : select legal issues
Armstrong, Kathryn B., author.
[Washington, D.C.] : Congressional Research Service, 2018-

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
28
2018
BOOK
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on H
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.C 73/8:115-10    AVAILABLE
29
2018
E-REPORT
Examining FDA's Medical Device User Fee Program : hearing before the Subcommittee on Health of the C
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
30
2018
BOOK
Examining FDA's Medical Device User Fee Program : hearing before the Subcommittee on Health of the C
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.C 73/8:115-20    AVAILABLE
31
2019
E-REPORT
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Publishing Office, 2019.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
32
2019
BOOK
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Publishing Office, 2019.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.C 73/8:115-96    AVAILABLE
33
2019
E-REPORT
Examining the public health risks of carcinogens in consumer products : hearing before the Subcommit
United States. Congress. House. Committee on Oversight and Reform. Subcommittee on Economic and Consumer Policy, author.
Washington : U.S. Government Publishing Office, 2019.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
34
2018
BOOK
Exploring current practices in cosmetic development and safety : hearing of the Committee on Health,
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.L 11/4:S.HRG.114-804    AVAILABLE
35
2018
E-REPORT
Exploring current practices in cosmetic development and safety : hearing of the Committee on Health,
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
36
2005
E-BOOK
FDA administrative enforcement manual
Parker, Florence R.
Boca Raton, FL : Taylor & Francis, ©2005.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE
37
2008
E-REPORT
FDA advisory committees process for recruiting members and evaluating potential conflicts of interes
United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
38
2020
E-REPORT
FDA drug approval : application review times largely reflect FDA goals : report to congressional re
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
39
2009
E-REPORT
FDA food facility registry.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2009.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
40
1991
E-REPORT
FDA food safety inspection.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1991.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
41
2016
E-REPORT
FDA is issuing more postmarketing requirements, but challenges with oversight persist.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2016.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
42
2017
E-REPORT
FDA medical device reviews, evaluation is needed to assure requests for additional information follo
United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2017.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
43
2018-
E-REPORT
FDA regulation of follow-on biologics
Johnson, Judith A. (Judith Ann), 1957- author.
[Washington, D.C.] : Congressional Research Service, 2018-

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
44
2014
E-BOOK
FDA regulatory affairs
Boca Raton, FL : CRC Press, [2014]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE
45
2008
E-BOOK

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE
46
2013
BOOK
FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, an
FDA user fees 2012 (2013)
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. Government Printing Office, 2013.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.C 73/8:112-126    AVAILABLE
47
2013
E-REPORT
FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, an
FDA user fees 2012 (2013)
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. Government Printing Office, 2013.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
48
2013
BOOK
FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Hea
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. Government Printing Office, 2013.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.C 73/8:112-136    AVAILABLE
49
2013
E-REPORT
FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Hea
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. Government Printing Office, 2013.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
50
2018-
E-REPORT
FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187
Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2018-

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
Save Marked Records Save All On Page
Locate in results
Result Page   1 2 3 Next